UCSF

Tagged: genomics

Michael Douglas

TRANSPERS Program Manager

As program manager for the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), my work focuses on the value of new technologies and how to most effectively and efficiently implement them into health care, with a particular focus on personalized (or precision) medicine...

Kevin Leung, PhD

Associate Researcher

My research focuses on:

target discovery for immuno-oncology using multi-omics approaches
generation of recombinant antibodies to relevant cell surface targets using phage display technologies.

Phillips discusses insurance coverage for genomic testing

Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

Fischbach joins project to generate drugs from bacterial genomes

Bacteria generate small molecules to fend off their fellow microbes. They also produce molecules that affect the response of host organisms—including humans—to their presence. Such molecules have been a major source of antibiotics, immunosuppressants, anti-cancer agents, and other drugs.

Burchard named to expert panel for Obama’s precision medicine plan

School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.

Diversity in Mexico

Kathryn Phillips, PhD

Professor

My work focuses on the translation of new technologies into improved patient outcomes, particularly the translation of personalized/precision medicine—targeting health care interventions to patients based on their genetics—into clinical care and health policy.

Nadav Ahituv, PhD

Professor

My research focuses on understanding how nucleotide variation in gene regulatory elements can lead to human disease and other phenotypes. 

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Genotyping could lead to stereotyping

While tailoring medications to a group's genetic ancestry can be important, scientists warn that these generalizations might also be misleading.